Technology | May 26, 2009

Mentice Offers VIST Enhanced Carotid, Coronary 7.7 Training Modules


The new and enhanced VIST Enhanced Carotid and Coronary 7.7 training modules, from Mentice, feature vital signs, complications, medication management and measurement functionality enhance to create clinical realism and elevate the educational value of simulation training. The system includes new patient cases, including chronic total occlusion and transradial access. The company said these cases challenge the learner to modify previously acquired skills to meet new procedural objectives. ?? The system offers vital signs recognition and response. ECG signals are derived from a model that recognizes a lack of oxygen supply to the heart. Any action that reduces oxygen supply will create changes in the ECG read out, requiring a trainee response. A select number of cases present complications that will occur as a result of trainee actions. For example, inserting a catheter too deeply into an ostium could result in spasm. Other complications are dissection, bradycardia and hypotension. Medication administration is now included to manage the complications the trainees encounter. Multiple cognitive decisions are required in this functionality, such as what medication, how much and how often. New measurement functionality allows the trainee to measure thing such as the diameter and length of lesions and reference vessels.

 


Related Content

News | Cath Lab

June 18, 2026 — Allegheny Health Network's (AHN) Allegheny General Hospital (AGH) has completed a $19 million renovation ...

Home June 18, 2026
Home
News | Cath Lab

May 28, 2026 — RWJBarnabas Health has earned Cardiac Catheterization Lab Accreditation from the American College of ...

Home May 29, 2026
Home
News | Cath Lab

May 13, 2026 — According to a recently released report, the global cath lab services market was valued at $46.0 billion ...

Home May 13, 2026
Home
News | Cath Lab

April 16, 2026 — A national study led by investigators from Cedars-Sinai Health Sciences University found that ...

Home April 20, 2026
Home
News | Cath Lab

April 6, 2026 —Stereotaxis has received U.S. Food and Drug Administration 510(k) clearance for its Synchrony system ...

Home April 07, 2026
Home
News | Cath Lab

March 31, 2026 — Solo Pace Inc. has announced the commercial release of the SoloPace Fusion Temporary Pacing System. The ...

Home April 03, 2026
Home
News | Cath Lab

March 25, 2026 — Royal Philips has launched its intuitive interventional guidance platform, IntraSight Plus, which is ...

Home March 26, 2026
Home
Feature | Cath Lab | Kyle Hardner

Since receiving FDA approval in 2016, intravascular lithotripsy (IVL) systems have grown in popularity among ...

Home November 14, 2025
Home
News | Cath Lab

Nov. 11, 2025 — FastWave Medical has successfully completed enrollment in its 30-patient coronary feasibility study and ...

Home November 13, 2025
Home
News | Cath Lab

Oct. 28, 2025 — Results from the first-of-its-kind randomized PROCTOR trial found that a strategy of saphenous vein ...

Home November 04, 2025
Home
Subscribe Now